Researchers have found a protein that seems to protect brain cells …
WEBJul 24, 2024 · A study of 48 post-mortem brains found a protein that appears to protect brain cells from Alzheimer's — even in people who had significant amounts of amyloid plaques in their brains.
FDA fully approves Leqembi, first drug shown to slow Alzheimer's ...
WEBJul 6, 2023 · The Food and Drug Administration has fully approved the first drug shown to slow down Alzheimer's disease. The action means that Leqembi, whose generic name is lecanemab, should be widely...
New Drug Approved for Early Alzheimer’s - The New York Times
WEBJul 2, 2024 · The Food and Drug Administration on Tuesday approved a new drug for Alzheimer’s disease, the latest in a novel class of treatments that has been greeted with hope, disappointment and skepticism.
A Blood Test Accurately Diagnosed Alzheimer’s 90% of the Time, …
WEBJul 28, 2024 · The results, presented Sunday at the Alzheimer’s Association International Conference in Philadelphia, are the latest milestone in the search for affordable and accessible ways to diagnose...
With new therapies that promise to slow Alzheimer’s disease ...
WEBJul 16, 2023 · Under new draft guidelines for the diagnosis of Alzheimer’s disease, unveiled on Sunday at a large international gathering of physicians and researchers, these memory tests would take a...
Second Alzheimer’s drug to slow disease’s progression may be ... - CNN
WEBJul 17, 2023 · The full approval this month of the Alzheimer’s drug Leqembi marked a historic shift in the treatment of the disease: For the first time, doctors have a medicine to prescribe that has been...
Leqembi and Alzheimer’s: What to Know About the New Drug, …
WEBJun 10, 2024 · Alzheimer’s is the most common form of dementia, but much remains unknown about this daunting disease. How is Alzheimer’s diagnosed? What causes Alzheimer’s?
Start of new era for Alzheimer’s treatment — Harvard Gazette
WEBJun 5, 2023 · Researchers say we appear to be at the start of a new era for Alzheimer’s treatment. Trial results published in January showed that for the first time a drug has been able to slow the cognitive decline characteristic of the disease.
New Treatment Reverses Alzheimer’s Disease Signs
WEBDec 20, 2023 · PHILADELPHIA – A “chaperone” molecule that slows the formation of certain proteins reversed disease signs, including memory impairment, in a mouse model of Alzheimer’s disease, according to a study from researchers at the Perelman School of Medicine at the University of Pennsylvania.
FDA Converts Novel Alzheimer’s Disease Treatment to Traditional ...
WEBToday, the U.S. Food and Drug Administration converted Leqembi (lecanemab-irmb), indicated to treat adult patients with Alzheimer’s Disease, to traditional approval following a determination ...